EGFR and skin squamous cell carcinoma: Importantly, miR-634 overexpression synergistically enhanced epidermal growth factor receptor (EGFR) TKI-induced cytotoxicity through the reduction of glutaminolysis by downregulating ASCT2, a glutamine transporter in cSCC cells [23].